RSS Feeds
Chloroquine and Nonconvulsive Status Epilepticus
- Paul Mulhauser, MD;
- Yves Allemann, MD; and
- Claude Regamey, MD
- Hopital Cantonal; 1708 Fribourg; Switzerland
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
We describe an otherwise healthy 68-year-old woman who was receiving prophylactic antimalarial doses of chloroquine (100 mg daily) while traveling in …
